Milsaperidone (Bysanti®) was FDA approved in February 2026 for the treatment of schizophrenia in adults and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. With a bridging package, milsaperidone reached FDA approval roughly five years after entering the clinic.
Read it on Drug Hunter: https://t.co/rOwktG1gvN
Did you know that CHF(Bpin)2 can serve as an efficient C1F1 synthon for synthesizing α‑fluoroketones from a wide range of methyl esters? Check out our @RamKumar9687@osi_lv work in @JOC_OL https://t.co/ZPKnSpAXN3
Check out our new tutorial review in @green_rsc !!
👉👉https://t.co/KF8oXdkxYO
Rethinking photocatalysis: TADF compounds challenge metal-based complexes as efficient, sustainable alternatives—even in energy transfer.
@discunipd@KAELMEUR
NIRI is taking shape by uniting scientific excellence, experience, and ambition. 🚀
~400 scientists + international talent + strong funding track record = a powerful life sciences deep-tech platform for next-gen medicines & vaccines.
#NIRI#LifeSciences#DeepTech#Innovation
Fluorinated Biradicals for 19F Magic-Angle Spinning Dynamic Nuclear Polarization-Enhanced NMR Spectroscopy | Journal of the American Chemical Society https://t.co/zxcIhGhqtv
Red-Light Photoredox C–H Alkylation Enabled by Catalytic NADH, now out in @ChemRxiv
https://t.co/UstcSM37eZ
From synthetic application to TAS mechanistic understanding, passing through radical biocompatibility.
Awesome collaboration between @ciqususc@MetBioCat and @CadraLab
We are pleased to share our Nat Rev Chem review! We summarize how photo-, electro-, and electrophotochemical strategies are reshaping C–N bond formation, distinguishing them from traditional metal catalysis toward more sustainable synthesis. @natrevchem https://t.co/GaLCYljvAD
Excited to share our latest work is now out on @J_A_C_S !!!!
We report a visible-light-driven platform for alkyl radical generation from redox-inert substrates based on photo-active sulfur-intermediates formed via polar activation.
https://t.co/4wMM3haOXD
Our latest paper has been published in @ChemCommun !
“Synthesis of sulfur- and oxygen-bridged cationic [4]-helicenes mediated by Friedel–Crafts-SNAr tandem reactions for red-light-driven organophotoredox catalysis”
@YutaGoto1557196#OpenAccess
https://t.co/2vMgViH9T2
A new method from the @Shenvi_Lab enables the construction of branched molecular frameworks from simple alkenes via controlled MHAT chemistry, resolving a longstanding selectivity challenge and accelerating access to drug-relevant structures, as reported in @ScienceMagazine. More: https://t.co/40ETE5Wv63
Chemistry that forms an omnipresent type of carbon–carbon bond enables the modular synthesis of 3D organic molecules — a boon for drug discovery and materials design
https://t.co/IRwCJifK8y
Check out our latest work (preprint) on Synthesis of "Alpha-Fluoroketones" From Carboxylic Acid Esters and Diborylfluoromethane (C1F1 Synthon)- Advanced Ketone Building Blocks- For MedChem and Drug Discovery!
https://t.co/lMUnLegdQd
@osi_lv@j_veliks#ANMGrant
Today we welcome students for Shadow Day at LIOS — sharing what drives us in drug discovery, organic synthesis & biopharmaceutics, and the journeys behind these careers. 👀🚀🌊
#LIOS#OSI#ShadowDay#LifeSciences